Pharmaceutical Marketing Council Best Practices & Research

Below you will find articles, white papers, and publications relevant to pharmaceutical marketers. Please note that most of the listings are only available to DMA Pharmaceutical Marketing Council members.

Executive Summary: 2004 DTC Industry Check Up by Paul Buta, Chief Operating Officer, Optas; and Dominique Hurley, VP of Marketing, Optas (DMA Pharmaceutical Marketing Council Members Only) The pharmaceutical industry is seeing a rapid change in direct-to-consumer marketing. Mass media advertising is losing its impact on an increasingly informed, skeptical, and proactive consumer audience. Newspaper and magazine articles, as well as TV news shows, lament the vast sums of money that pharmaceutical companies spend on marketing as they link this marketing spend to the perceived high cost of drugs. Compliance and persistence are low and may be headed lower with the recent product recalls. How well are DTC marketers prepared to address these challenges?
The DMA 2004 Response Rate Report - Health Services Section
The DMA DirectLink's Pharmaceutical Section (DMA Pharmaceutical Marketing Council Members Only) A sample of resources posted in The DMA's online searchable database
FAQs on HIPAA Frequently asked questions on the privacy provisions of the Health Insurance Portability and Accountability Act (HIPAA)